Singapore markets closed
Straits Times Index
3,204.82 +2.01 (+0.06%) Nikkei
32,402.41 -168.62 (-0.52%) Hang Seng
18,057.45 +402.04 (+2.28%) FTSE 100
7,683.91 +5.29 (+0.07%) Bitcoin USD
26,588.84 -5.95 (-0.02%) CMC Crypto 200
565.87 -2.18 (-0.38%)
Aeterna Zentaris Inc. (AEZS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 03:58PM EDT
After hours:
| Previous close | 2.5700 |
| Open | 2.5290 |
| Bid | 2.4400 x 1000 |
| Ask | 2.4600 x 1400 |
| Day's range | 2.3904 - 2.6500 |
| 52-week range | 2.3200 - 4.4000 |
| Volume | |
| Avg. volume | 9,577 |
| Market cap | 12.14M |
| Beta (5Y monthly) | 1.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.5400 |
| Earnings date | 01 Nov 2023 - 06 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksAeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue Estimates
Aeterna Zentaris (AEZS) delivered earnings and revenue surprises of 40.23% and 104.18%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksAeterna (AEZS) Falls 5% on US Sales Halt of Growth Hormone Drug
Aeterna Zentaris (AEZS) announces halting sales of adult growth hormone deficiency diagnosis drug, Macrilen, in the United States in the absence of a commercialization partner. Stock down 5%.
ZacksAeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates
Aeterna Zentaris (AEZS) delivered earnings and revenue surprises of 9.68% and 134.43%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
